Gil Blum

Stock Analyst at Needham

(4.18)
# 661
Out of 5,182 analysts
433
Total ratings
43.66%
Success rate
18.27%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Gil Blum

Lyell Immunopharma
Apr 10, 2026
Initiates: Buy
Price Target: $44
Current: $22.77
Upside: +93.24%
Autolus Therapeutics
Apr 9, 2026
Reiterates: Buy
Price Target: $10
Current: $1.42
Upside: +604.23%
Absci
Mar 30, 2026
Reiterates: Buy
Price Target: $7
Current: $4.85
Upside: +44.33%
Celcuity
Mar 26, 2026
Reiterates: Buy
Price Target: $122
Current: $125.68
Upside: -2.93%
Artiva Biotherapeutics
Mar 11, 2026
Reiterates: Buy
Price Target: $18
Current: $10.75
Upside: +67.44%
Immunocore Holdings
Feb 26, 2026
Maintains: Buy
Price Target: $71$75
Current: $28.56
Upside: +162.61%
Arcellx
Feb 23, 2026
Downgrades: Hold
Price Target: n/a
Current: $115.07
Upside: -
CRISPR Therapeutics AG
Feb 13, 2026
Maintains: Buy
Price Target: $80$82
Current: $50.99
Upside: +60.82%
Mereo BioPharma Group
Jan 13, 2026
Maintains: Buy
Price Target: $5$3
Current: $0.28
Upside: +970.66%
Geron
Aug 9, 2024
Reiterates: Buy
Price Target: $6
Current: $1.53
Upside: +292.16%
Reiterates: Buy
Price Target: $26
Current: $16.49
Upside: +57.67%
Maintains: Buy
Price Target: $10$11
Current: $2.83
Upside: +288.69%
Reiterates: Underperform
Price Target: n/a
Current: $20.98
Upside: -
Reiterates: Buy
Price Target: $19
Current: $7.50
Upside: +153.33%
Maintains: Buy
Price Target: $10$12
Current: $6.46
Upside: +85.76%
Reiterates: Buy
Price Target: $42
Current: $7.07
Upside: +494.06%
Reiterates: Buy
Price Target: $8
Current: $3.48
Upside: +129.89%
Downgrades: Hold
Price Target: n/a
Current: $14.49
Upside: -
Maintains: Buy
Price Target: $9$6
Current: $1.31
Upside: +358.02%
Reiterates: Hold
Price Target: n/a
Current: $1.31
Upside: -
Maintains: Hold
Price Target: n/a
Current: $3.49
Upside: -
Reiterates: Hold
Price Target: n/a
Current: $7.72
Upside: -
Reiterates: Buy
Price Target: $48
Current: $9.62
Upside: +398.96%